Pre-earnings options volume in Mineralys Therapeutics (MLYS) Inc is normal with puts leading calls 56:1. Implied volatility suggests the market is anticipating a move near 21.7%, or 0c, after results are released. Median move over the past eight quarters is 4.2%.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MLYS:
- Mineralys Therapeutics Inc options imply 13.2% move in share price post-earnings
- Mineralys Therapeutics Inc call volume above normal and directionally bullish
- Mineralys Targets Sleep Apnea and Hypertension With Lorundrostat: What Investors Should Watch
- Mineralys Therapeutics: Lorundrostat’s Broad Efficacy, Favorable Safety, and Upside Indications Support Buy Rating on MLYS
- Mineralys updates lorundrostat program and upcoming data milestones